DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /MorpholinesMorpholines
  6. /4-(Azetidin-3-yl)morpholine4-(Azetidin-3-yl)morpholine
Chemical structure of CAS 302355-79-9

4-(Azetidin-3-yl)morpholine

CAS No.302355-79-9
MDL No.MFCD09264459
MFC7H14N2O
MW142.20
InChI KeyGLHXYSFEVOAOSL-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.302355-79-9
Product Name4-(Azetidin-3-yl)morpholine
Heavy Atom Count10Rotatable Bond Count1
Atom Stereo Count0Bond Stereo Count0
HBA3HBD1
TPSA24.500 ŲCharge0
Exact Mass142.11061Complexity108.17
pKa2.025XLogP-0.710

Related Articles

Studies related to this compound and its mechanism of action

4-Amino-2-(aryl)-butylbenzamides and Their conformationally constrained analogues. Potent antagonists of the human neurokinin-2 (NK(2)) receptor.

Bioorganic & medicinal chemistry letters • Vol. 13, Issue 13 • 2003
PMID: 12798336DOI: 10.1016/s0960-894x(03)00343-3

Documentation

Similar Products

  • 4-(Azetidin-3-YL)morpholine hydrochloride

    CAS No.223381-71-3

  • 4-(Azetidin-3-yl)morpholine dihydrochloride

    CAS No.178312-50-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact